Product Reports Resources Pricing Login Book a demo

BONESUPPORT

Biotech & Life Sciences · Lund Municipality, Sweden · Founded 1999 · IPO 2017

BONESUPPORT is a medical technology company specializing in the development and commercialization of innovative injectable bioceramic bone graft substitutes. These substitutes are designed to promote bone healing and regeneration, providing an alternative to traditional bone grafts. The company primarily serves orthopedic surgeons, hospitals, and clinics that treat patients with bone disorders, fractures, and other skeletal conditions. Operating in the global healthcare market, BONESUPPORT focuses on regions including Europe, North America, and Asia. The company's flagship product, CERAMENT, is a synthetic bone graft substitute that can be combined with drugs to enhance bone healing. This product is particularly useful in treating bone infections, fractures, and defects, offering a less invasive and more effective solution compared to traditional methods. BONESUPPORT's business model revolves around research and development (R&D), manufacturing, and sales of its bioceramic products. The company invests heavily in clinical trials and scientific research to validate the efficacy and safety of its products. Revenue is generated through the direct sale of these products to healthcare providers and through partnerships with other medical companies. The company was founded by Professor Lars Lidgren in the early 2000s, with the vision of creating synthetic solutions to improve the quality of life for patients with bone disorders. Over the years, BONESUPPORT has expanded its product pipeline to include combination products that release drugs to further enhance bone healing. The company continues to innovate, aiming to broaden the clinical applications of its technology. Key personnel include Kristina Ingvar, who oversees global quality and regulatory compliance, ensuring that BONESUPPORT meets stringent international standards. The company collaborates with various partners worldwide to expand its reach and impact in the medical field. Keywords: bioceramic, bone graft, orthopedic, CERAMENT, bone healing, synthetic, healthcare, medical technology, R&D, global market.

Valuation $1.69B
Revenue $180M
EBITDA $51M
Total funding $50–100M

Investors

14 investors on BONESUPPORT's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
European Innovation Council
Series A 6 investors entered at this stage
Innovations Kapital
Ferd
Teknoinvest
HealthCap
NBGI Ventures
Vencorp Partners
Series B+ 7 investors entered at this stage
Industrifonden
Lundbeckfonden
Lundbeckfonden Ventures
IPF Partners
Kreos Capital
AP3
SEB

Global footprint

Where BONESUPPORT has talent and traffic

Workforce by country
14 countries with
team presence
🇸🇪 Sweden40%
🇺🇸 United States35.6%
🇬🇧 United Kingdom8.8%
🇩🇪 Germany5%
🇳🇱 Netherlands1.9%
Top 5 of 14 shown
Web traffic by country
7.8K monthly visits
across markets
🇺🇸 United States38.5%
🇬🇧 United Kingdom25.6%
🇸🇪 Sweden20.5%
🇮🇳 India6.4%
🇩🇪 Germany3.8%
Top 5 markets shown

Talent graph

The shape of BONESUPPORT's talent

Dealroom maps BONESUPPORT's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

21 team members profilednamed & role-tagged by Dealroom
206 employeestotal headcount
2 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock BONESUPPORT's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$5M patent portfolio · 4 active families

Estimated portfolio value
$5M
0.32% of market cap · 13.4× smaller than top peer Nevro ($72M)
4 active patent families
Where BONESUPPORT innovates Bone cementCalcium biphosphateMaterials scienceMedicineNon invasive

Where BONESUPPORT concentrates vs peers

Each axis is a top-10 topic across BONESUPPORT and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about BONESUPPORT

An AI-synthesized read of the highest-engagement posts about BONESUPPORT on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BONESUPPORT on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.